Tag: johnson and johnson

Johnson & Johnson Lead Scientist and Executive Admit Baby Powder Contained ‘Cancer-Causing Heavy Metals’

The O’Keefe Media Group on Friday released undercover video of a Johnson & Johnson lead scientist and executive admit that baby power contained cancer causing heavy metals.

This is the second undercover video in OMG’s series exposing Johnson & Johnson.

Joshua Rys, a Regulatory Affairs Scientist who managed Johnson & Johnson’s baby products spilled the truth to an OMG undercover journalist.

“When I started, actually I started working on the consumer group. Johnson’s was one of my brands. So I managed all the baby products. So actually, when that all happened, I was working on that,” said Joshua Rys.

Rys continued, “It wasn’t actually the product itself, it was an impurity. So naturally talc comes from mines, and the mines don’t have, I guess, 100 percent accurate standards. So the heavy metals, it’s not the talc itself that gives you the cancer, it’s the heavy metals that are in there.”

David Altman, Executive & Senior Clinical Analyst at Johnson & Johnson, said, “This is not your father’s J&J… they don’t really give a sh*t about people.”

Keep reading

 Johnson & Johnson Lead Scientist Confesses J&J COVID-19 Vaccine Was ‘Not Safe and Effective,’ Reveals “Lack of Research” From Rushing to Release Vaccine: “People Wanted It, We Gave It to Them”

“We didn’t do the typical tests,” said Joshua Rys, a Lead Scientist in Regulatory Affairs for Johnson & Johnson (J&J), revealed on hidden camera that the typical clinical process was abandoned for the COVID-19 vaccine, knowingly bypassing standard testing protocols under pressure from the U.S. government and public demand. He added, “This was just, ‘let’s test it on some lab models… and just throw it to the wind and see what happens.’”

He acknowledged that the public wasn’t informed about the shortcuts, asking, “Do you have any idea the lack of research that was done on those products?” Rys claimed, “People wanted it, we gave it to them.”

While public officials claimed the vaccines were “safe and effective,” Rys pushed back. “There’s no proof. None of that stuff was safe and effective,” he said, adding that the industry relies on a benefit-risk tradeoff to justify product launches.

Rys also pointed to government pressure through Operation Warp Speed. “The government is like, ‘We need help… You’re solving this problem,’” he said. “People panic, so they try to solve it in whatever way they think is good.”

According to a U.S. Department of Health and Human Services (HHS) spokesperson, “Even during a public health emergency, pharmaceutical companies are still required to follow strict protocols for clinical testing. For emergency use, companies must show that the benefits clearly outweigh the risks. Oversight doesn’t stop at approval — the FDA and other agencies also monitor products closely once they’re in use. That includes real-world safety tracking, independent advisory committees, and required reporting of any adverse events. These steps are in place to make sure public health decisions are based on solid science and strong safeguards — especially in emergencies.

Dr. Marty Makary and Dr. Vinay Prasad recently announced a new vaccine safety and transparency framework — one that’s built on gold-standard science, real-world data, and honest communication with the public and will require thorough safety testing before licensing. Their work is focused on strengthening trust, improving how we monitor safety after vaccines are in use, and making sure people have clear, accurate information to make informed decisions.

HHS remains committed to full transparency and evidence-based oversight — putting the safety of the American people first.”

Keep reading

J&J’s ketamine-derived nasal spray approved by FDA to treat depression

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression.

Spravato, approved as a standalone treatment, is “the first and only monotherapy for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,” the pharmaceutical giant said Tuesday. 

An estimated 21 million adults in the U.S. are living with major depressive disorder, one of the most common psychiatric disorders, but one-third of them will not respond to oral antidepressants alone, hindering their quality of life, according to Johnson & Johnson. 

“Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants or cannot tolerate them. For too long, healthcare providers have had few options to offer patients much-needed symptom improvement,” Bill Martin, global therapeutic area head of Neuroscience at Johnson & Johnson Innovative Medicine, said in a statement. 

Keep reading

J&J helped fund 1971 study where ASBESTOS was injected into mostly black inmates paid up to $300 to determine if deadly substance was safe to use in talcum powder

Pharmaceutical giant Johnson & Johnson helped fund a 1960s prison experiment when a group of majority-black Pennsylvania prisoners were injected with asbestos to determine whether the substance was safe to use in talcum powder.

Documents confirming the company’s involvement were obtained by Bloomberg, tying the New Jersey-based company to controversial experiments led by Dr Albert Kligman, a University of Pennsylvania dermatologist whose human experiments have widely condemned as brutal and unethical. He died in 2010 aged 93. 

Inmates at Holmesburg Prison in Philadelphia, Pennsylvania, were offered $10 to $300 – equivalent to between $100 to $2,500 in today’s money when adjusted for inflation – to take part in the study – though they were likely unaware of the significant risk they were undertaking.

Participants were injected with asbestos and talc – a powder that forms the base of J&J’s iconic baby powder product. Asbestos is an extremely dangerous chemical that is tied to lung cancers, among other conditions. 

Keep reading

J&J Vaccine Possibly Linked To Two More Serious Health Conditions, EU Regulator Finds

The European Union’s drug regulator on Oct. 1 recommended updating the label for Johnson & Johnson’s COVID-19 vaccine with warnings for two more serious health conditions likely linked with the vaccine.

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded that the use of the J&J vaccine is possibly linked with vein clotting and an immune condition that causes the immune system to attack blood platelets.

“The PRAC has concluded that there is a possible link to rare cases of venous thromboembolism (VTE) with COVID-19 Vaccine Janssen,” the committee meeting highlights stated.

Venous thromboembolism “is a condition in which a blood clot forms in a deep vein, usually in a leg, arm, or groin, and may travel to the lungs causing a blockage of the blood supply, with possible life-threatening consequences,” the committee said.

Janssen, a J&J company, did not respond to a request for comment.

After reviewing new evidence, PRAC concluded that there is a “reasonable possibility” that the clotting condition is linked with vaccination using the J&J vaccine. The committee recommended listing venous thromboembolism as a rare side effect in the product information for the J&J vaccine.

The committee also found that the use of the J&J and the AstraZeneca vaccines is linked to an immune condition that causes the body’s immune system to target healthy platelets needed for normal blood clotting.

Keep reading

Two Johnson & Johnson Officials Say In Hidden Recording That Children Shouldn’t Get Vax Due To ‘Unknown Repercussions’

Project Veritas is out with the third installment of their series on vaccine insiders – this time covertly recording two Johnson & Johnson officials saying that children don’t shouldn’t take the Covid-19 jab.

“Kids shouldn’t get a f*cking [COVID] vaccine,” said regional business lead, Brandon Schatt.

“It’s a kid, you just don’t do that, you know? Not something that’s so unknown in terms of repercussions down the road, you know?”

Schadt also implied that the huge push to vaccinate children is about money, not public safety.

“J&J is like stepping in the best smelling pile of sh*t you could step in,” he said.

Another J&J employee, scientist Justin Durrant, explicitly said “Don’t get the Johnson & Johnson [COVID vaccine], I didn’t tell you though.”

As for children, Durrant said “It wouldn’t make that much of a difference.”

He also commented on the pressure campaign to restrict social privileges for the unvaccinated.

Keep reading

FDA is set to announce new warning on J&J vaccine after 100 reports of it being linked to rare autoimmune disease Guillain-Barré syndrome

The U.S. Food and Drug Administration (FDA) is set to announce a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease.

Four people familiar with the situation told The Washington Post that the shot has caused instances of Guillain-Barré syndrome, a rare disorder in which the immune system attacks the peripheral nervous system, temporarily paralyzing parts of the body.

The Centers for Disease Control and Prevention (CDC) is said to have received about 100 preliminary reports of Guillain-Barré following the one-dose vaccine   

Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older. 

With just 100 cases reported out of 12.8 million doses administered, this means the condition is very rare occurring in just 0.000781 percent of cases.

The warning is yet another setback for J&J’s vaccine, which has plagued by pauses, ingredient mix-ups and doses needing to be thrown out.

Keep reading